DAVID BRITT: Open Payments
NPI 1265424824 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 68 payments from 20 companies in 2025. Trend: 2023 $2,377 · 2024 $1,830 · 2025 $1,541
Food & beverage: $1,541
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $322 |
| AstraZeneca Pharmaceuticals LP | 5 | $293 |
| Indivior Inc. | 6 | $136 |
| Novo Nordisk Inc | 6 | $125 |
| Amgen Inc. | 7 | $112 |
| Braeburn Inc. | 5 | $102 |
| PFIZER INC. | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Antares Pharma, Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $43 |
Products named: AIRSUPRA, VRAYLAR, SUBLOCADE, BRIXADI, UBRELVY, JARDIANCE, Ozempic, Auvelity.
Industry payments across KY — which companies pay providers there.
